{
  "trial_id": "NCT03477240",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "approximately 1-2 weeks prior to her expected date of follow up",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "conversation and invited to participate in the study",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "verbal telephonic consent is obtained",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "interviewed by the clinical research nurse using the format of the prepared proforma (Form A)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "symptoms suggestive of disease recurrence as well as treatment induced toxicity",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "worrisome symptoms of disease or not and has symptoms of treatment toxicity or not for which she should visit the hospital",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "short written informed consent",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "complete history and in addition, performs a physical examination and any investigations he/she deems necessary",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "final impression of disease status and toxicity which are taken as the gold standard (Form B)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "information regarding the acceptability of nurse-led telephonic follow-up to the patient and the financial impact of physical follow- up will be collected using a structured format (Form C)",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Study participant drop-out/ Lost-to-follow up: Patients may withdraw their consent at any point during the telephonic interview or the subsequent follow up visit",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "A patient who does not attend the scheduled follow up visit within 1-2 weeks of the telephonic interview will be called a second time to remind her of the follow up appointment and enquire about reasons for non-attendance in the clinic, which will be recorded",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Those patients in whom the interval between telephonic interview and the physician's assessment is more than 4 weeks, will be considered drop outs and follow up telephone call will go out to enquire about reasons for non-attendance in the clinic, which will be recorded",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients with Stage III disease treated with palliative intent with once monthly radiotherapy",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Early stage cervical cancer patients who underwent Wertheims hysterectomy and who have completed adjuvant radiochemotherapy due to high-risk factors",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Metastatic cervical cancers",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Patients who are unable to comprehend the questions or dialogue over telephone by medical staff",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Patients who seem unreliable for follow up",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "The patient has Turner syndrome, is treating with GH, and has a history of developmental delay. She is obese and mentally retarded.",
  "_meta": {
    "topic_id": "49",
    "trial_id": "NCT03477240",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}